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SUMMARY
Objective: To draw attention to complications that might arise in any Kawasaki disease 
(KD) stage, risk factors contributing to the onset of complications and possible transient 
or permanent disease sequelae. Methods: Prospective study (clinical cohort) conducted 
between April 2002 and April 2009 of 115 patients with KD admitted to the Pediatric 
Rheumatology Clinic of the General Hospital of the Federal District, Brazil. All patients 
were sequentially assessed with clinical and laboratory examinations, Doppler echocar-
diography, imitanciometry, auditory evoked potentials, psychological evaluation, oph-
thalmologic examination and, in one patient with chorea, cerebral magnetic resonance 
angiography. In all patients, a questionnaire assessing the possible presence of cognitive, 
emotional, behavioral and social disorders was applied. Results: Twenty-five patients 
(21.7%) had coronary aneurisms. Thirty-eight patients (33%) had a sensorineural audi-
tory loss during the acute and subacute phases of the disease and 13 patients (11.3%) 
maintained the auditory loss six months after the first assessment. Other complications 
observed were as follows: facial palsy in one patient (0.9%), ataxia in acute and subacute 
phases in 11 (9.5%); 15 patients had ophthalmologic complications (13.2%), with uveitis 
in 13, papilledema in one patient, and conjunctival hemorrhage in another patient. One 
patient experienced chorea (0.9%), with a magnetic resonance angiography showing 
changes consistent with cerebral ischemia. In one patient, a thoracic aorta aneurism was 
found (0.9%) and another patient had a necrotizing vasculitis progressing to peripheral 
gangrene and tongue tip loss (0.9%). Behavioral changes over convalescence were ob-
served in 23 children. Conclusion: KD may progress with several complications even 
within months of the disease acute phase, eventually resulting in permanent sequelae. 
The earlier the diagnosis and therapeutic intervention with IV IgG administration are, 
the lower will be the occurrence of complications; the presence of thrombocytosis, ane-
mia and elevated and extended inflammatory activity are risk factors for complication 
arising.
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INTRODUCTION
Kawasaki disease (KD), also known as mucocutaneous 
lymph node syndrome, is a primary vasculitis often seen 
in childhood, being mediated by IgA1, aí ecting more fre-
quently small- and medium-size vessels and it can lead to a 
fibrinoid necrosis in vessel walls. The disease compromis-
es vessels from the intima layer to the perivascular area, 
forming aneurisms in several dií erent stages in a child-
hood polyarteritis. This is a systemic vasculitis, but prefer-
entially found in coronary arteries2.
KD diagnosis is purely clinical, based on the presence of 
fever persisting for at least five days and further four out 
of five diagnostic criteria: limb changes, such as hand and/
or foot erythema or swelling during the acute stage and 
fingertip scaling over convalescence; polymorphous exan-
thema; bilateral conjunctivitis with no purulent discharge, 
lip erythema and cracking, raspberry tongue, throat red-
ness and anterior cervical adenopathy with a 1.5 cm or 
larger size. As there are no specific laboratory markers, a 
high level of suspicion is required, usually resulting in a 
rise in the number of cases diagnosed3.
The most severe complication of the disease is coronary 
vasculitis, leading to coronary artery changes and aí ect-
ing 15%-20% of patients if left untreated4. These changes 
include aneurisms, coronary artery ectasias and stenoses, 
responsible for 2% of mortality. The intravenous immuno-
globulin G (IVIG) administration over the 10 first days of 
the disease leads to a reduced coronary artery impairment 
of 3%-8% and mortality to 0.2%2,3.
Other KD complications have been described, such 
as aneurisms of other arteries: aortic aneurisms, with a 
higher number of reported cases involving the abdominal 
aorta5-7; axillary artery aneurism8; brachiocephalic artery 
aneurism9; aneurisms of iliac and femoral arteries, and re-
nal artery aneurism10,11.
Gastrointestinal complications in KD are described in 
the literature as case reports similar to those observed 
in Henoch-Schönlein purpura, such as: intestinal obstruc-
tion12, colon swelling13, intestinal ischemia14, intestinal 
pseudo-obstruction15 and acute abdomen16.
Ophthalmologic changes associated with KD have 
been described since the 1980’s, being found as uveitis, 
iridocyclitis, conjunctival hemorrhage17-19, optic neuritis20, 
amaurosis and ocular artery obstruction21.
KD can also be found as necrotizing vasculitis, pro-
gressing into peripheral gangrene, according to a number 
of case reports22-24 described in the literature.
The neurological complications per central ner-
vous system (CNS) lesion are increasingly found in lit-
erature. The neurological complications found are me-
ningoencephalitis25,26, subdural eí usion27,28, cerebral 
hypoperfusion29, cerebral ischemia and infarct30, cerebelar 
infarction31, manifesting with seizures, chorea, hemiplegia, 
mental confusion, lethargy and coma8 or even a cerebral 
infarction with no neurological manifestations30,31.
Other neurological complications from cranial nerve 
involvement are reported as ataxia3, facial palsy32-34 and 
sensorineural auditory loss35-37.
The first description for hearing loss in KD was made 
by Suzuki et al.35 in Japan in 1988. In 1992, Sundel et al.36 
assessed 40 patients by standard audiometry and BERA 
(Brainstem Evoked Response Audiometry) in patients 
who could not undergo an audiometry. Seven patients 
(17.5%) had a sensorineural auditory loss and 14 patients 
had an inconclusive result. In 2001, Knott et al.37 reported 
another study where they performed an audiological as-
sessment in 62 patients over the first thirty days of KD; 
from these, 13 had a sensorineural auditory loss and two 
patients kept the sensorineural auditory deficit in a second 
audiological assessment 10 days later.
Behavioral changes, such as attention deficits, learn-
ing deficits, emotional disorders (emotional lability, fear 
of night and night terrors) and internalization problems 
(anxious, depressive or aggressive behavior) have been 
described in studies in the literature38,39 conducted on 
the basis of the questionnaires Child Behavior Check List 
(CBCL4-18/1991), Strengths and Dií culties Question-
naire (1997) and Parenting Stress Index (PSI/1983).
The purpose of the current study was to obtain data 
regarding KD complications and identify the incidence of 
theses complications in a sample of 115 cases followed in 
a clinic specialized in pediatric rheumatology in Brasília, 
Brazil. The objective of the study was to draw attention to 
the diagnosis of KD complications that are likely to oc-
cur even after the acute and subacute stages of the disease, 
possible transient or permanent sequelae and risk factors 
for these complications.
METHODS
A clinical cohort of patients with Kawasaki disease was 
used and followed in the Pediatric Rheumatology Clinic 
of Hospital de Base do Distrito Federal (HBDF). The study 
evaluated 115 patients having KD diagnosed in accor-
dance with the American Heart Association (AHA)3 crite-
ria. The patients were seen at the Pediatric Rheumatology 
Clinic of the HBDF from April 2002 to April 2009 (inclu-
sion criteria). The incomplete KD forms and the patients 
having conditions that could lead to the same complications 
assessed were excluded. All patients provided an informed 
consent to participate in the study, which was approved by 
the Research Ethics Committee of Brasilia Health Secretary.
All of the 115 patients were followed with sequential 
clinical and laboratory examinations, echocardiography, 
brainstem auditory evoked potential (BERA) study and 
imitanciometry, ophthalmologic assessment with bio-
microscopy and fundus examination, and psychological 
evaluation over the follow-up. Only one patient having 
chorea underwent a magnetic resonance angiography. All 
patients were treated with intravenous immunoglobulin at 
the diagnosis.
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Clinical and laboratory examinations, as well as the 
echocardiograms, were performed at the admission, one 
month later and thereafter three-month apart in the first 
year after the DK onset and six-month apart later, being 
performed by the same cardiologist and using the same 
echo-Doppler apparatus (ALOKA SSD 2200, with 2.5 and 
5.0MHz transducer made in Japan).
The ophthalmologic examination was performed dur-
ing KD acute and subacute stages after the first examina-
tion in all patients.
A questionnaire based on questionnaires Child Be-
havior Check List (CBCL4-18/1991); Strengths and Dif-
ficulties Questionnaire (1997); Parenting Stress Index 
(PSI/1983), assessing cognitive, emotional, behavioral or 
social di culties was applied to all patients 30 days after 
the acute phase. The patients having behavioral, emotional 
or cognitive disorders were given periodical psychological 
follow-up.
The imitanciometry was initially performed in all pa-
tients to exclude those with an hearing loss from conduc-
tive changes. The AZ7 INTERACOUSTICS (Denmark, 
2000) imitanciometer was used in auditory assessment. 
The auditory assessment was made through Brainstem 
Evoked Potentials (BERA) in all patients over the first 30 
days of disease and six months later in patients having a 
hearing loss initially. The equipment used for BERA was 
MEDELEC SAPHIRE IV PREMIERE PLUS (England, 
1996) with silver surface electrodes in positions based on 
the international system 10-20-Fz, A1, A2.
STATISTICAL ANALYSIS
The Pearson’s chi-squared test was used to find the associa-
tion between KD complication occurrence and the follow-
ing variables: thrombocytosis (platelet level over 500,000); 
anemia with hemoglobin under 10g/dL; ESR over 50mm 
for more than 30 days and IVIG treatment in the acute 
phase and after the acute phase. Dierences with a p<0.05 
were considered statistically significant. The software SAS 
9.2 for Windows was employed for data analysis.
RESULTS
Out of 115 patients, 77 (67%) were males, and the patients’ 
ages ranged from two months to 11 years, with a mean of 
3.2 years. Eighty-five were Caucasian, 24 had a dark com-
plexion, 1 was Afrodescendant and 5 were Japanese de-
scendants. Seventy-four per cent of patients were younger 
than five years old.
All patients received intravenous immunoglobulin 
(IVIG) 2flg/kg/dose although only 58 (%) were given IVIG 
within the first 10 days of disease.
Twenty-five patients (21.7%) had coronary aneurisms, 
with four patients having aneurisms in both coronary ar-
teries, one only on the right artery and 20 only on the left; 
two of them were middle-sized and the others were small. 
Out of the 25 patients having a coronary aneurism, four 
patients were under six months old, and two were older 
than 5 years; 10 patients used gamma globulin in acute 
phase and 15 patients in the subacute phase.
One patient (0.9%) had a thoracic aorta aneurism diag-
nosed in the subacute phase through the histopathological 
study of the aneurism and the clinical history data.
Thirty-eight patients (33%) had a sensorineural au-
ditory loss during the acute and subacute phases of the 
disease and 13 (11.3%) were keeping the hearing loss six 
months after the first assessment. Out of these 38 patients, 
20 used gamma globulin in the subacute phase.
One patient had a facial palsy in the subacute phase 
and 11 patients (9.5%) had ataxia, with 30% in the acute 
phase and the others in the subacute phase. The presence 
of ataxia was observed in patients with high and extended 
inflammatory activity.
Fifteen patients (13.2%) had ophthalmologic compli-
cations: 13 had an anterior uveitis, one had a papilledema 
and another patient had a conjunctival hemorrhage, 40% 
in the acute phase, the others in the subacute phase, and 
these complications were not maintained in the second 
ophthalmologic assessment 30 days later.
A patient had a course with chorea six months after 
the acute phase and it was controlled by using valproate; the 
brain magnetic resonance angiography showed lesions 
consistent with brain ischemia near the caudate nucleus. 
The changes were still present in a magnetic resonance an-
giography performed one year after the first study.
One patient with a high and extended inflammatory 
activity associated with anemia and thrombocytosis had a 
necrotizing vasculitis with peripheral gangrene and conse-
quent tongue tip loss.
Twenty-three (20%) patients had behavioral changes 
over the convalescence: all of them had irritability, 13 had 
a course with aggressiveness, nine with an attention defi-
cit, seven with a learning deficit and two with an antisocial 
behavior. Six patients remained with an aggressive behav-
ior, three with a learning deficit and five with an attention 
deficit six months after the acute phase.
Among the patients with a coronary aneurism, 4 kept 
the small left coronary artery aneurism for 9 months, two 
years, two and a half years and one patient has been keep-
ing a medium right coronary artery aneurism six years af-
ter the KD acute phase.
Five patients (4.3%) had an acute phase recurrence. 
Three of them used IVIG and two of them had a coronary 
aneurism. The other two used gamma globulin in the sub-
acute phase and one of them had a course with a coronary 
aneurism.
The most prevalent complications were: sensorineural 
auditory loss (33%), coronary artery aneurisms (21.7%), 
behavior and cognitive disorders (20%), ocular changes 
(13.2%), ataxia (9.5%), facial palsy (0.9%), peripheral gan-
grene (0.9%), aortic aneurism (0.9%), cerebral ischemia 
(0.9%) (Figurefl1).
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Figure 1 – Incidence of KD complications in a sample of 
115 patients referred to the Pediatric Rheumatology Clinic 
of HBDF from January 2002 to January 2011.
Table 1 – Relationship between KD complications and the presence of thrombocytosis (platelet count > 500,000), anemia 
with hemoglobin (Hb) < 10 mg/dL and ESR > 50 mm/h for over 30 days
Patients [n]
Platelets  
[>500,000]  
n (%)
Anemia 
[Hg <10 mg/dL] 
n (%)
ESR (> 50 mm/h) 
over 30 days 
n (%)
With KD complications 63 44 (70) 38 (62) 55 (87)
Without KD complications 52 21 (40) 13 (25) 23 (44.2)
Table 2 – Relationship between KD complications and IV immunoglobulin use over the acute phase and after the acute phase
Patients (n) IVIG over the acute phase, n (%) IVIG after the acute phase, n (%)
With KD complications 63 25 (40) 38 (60)
Without KD complications 52 33 (63.4) 19 (36.6)
The persistent complications were: coronary aneurism 
in four patients, sensorineural hearing loss in 13, behav-
ioral changes in six patients.
The complications were more frequent in patients hav-
ing more anemia, more thrombocytosis and higher and 
longer inflammatory activity (Table1). The incidence of 
complications in KD was higher in patients using IVIG 
after the ten days of disease progress (Table2). By statisti-
cal analysis, a significant association between frequency of 
complications and the following variables could be detect-
ed: anemia with Hb<10g/dL (p=0.0001); thrombocyto-
sis (p=0.0015); ESR>50mm/h for longer than 30 days 
(p = 0.0001); and IVIG treatment after the acute phase (10 
first days of disease) (p=0.0111).
DISCUSSION
Takahashi et al.40 observed in post-mortem studies of chil-
dren having KD with no echocardiography abnormali-
ties and dying years later from other causes that coronary 
arteries were markedly abnormal, with impressive pro-
atherosclerotic changes persisting even in the absence of 
acute lesions in this artery. This cardiovascular damage 
unrecognized or unidentified in the acute phase will mani-
fest later as a cardiovascular disease in the adult, explain-
ing many myocardial infarction in adolescents and young 
adults with no apparent cause41.
Coronary aneurisms were classified by a new guide-
line by AHA3 as small aneurisms (inner diameter from 
3 to 5mm), medium aneurisms (5 to 8mm) and giant 
(>8mm). Other changes that can be found in KD even 
in the absence of aneurisms are vessel ectasias or stenoses. 
Giant coronary aneurisms have a higher risk for thrombo-
sis, calcification and/or stenosis and consequently myocar-
dial infarction. Small- and medium-size aneurisms usually 
regress spontaneously and rarely generate other complica-
tions3.
Aortic aneurisms should also be assessed for and the 
aortic diameter should be measured with imaging studies 
because there are evidence the aorta dilation is common 
in patients with KD and these dilations do not regress over 
the first year of the disease5.
The incidence of CNS involvement in KD ranges from 
1.1% to 3.7%25,41, being found as seizures, ataxia, coma, 
lethargy, subdural eusion, hemiplegia, facial palsy and 
sensorineural hearing loss.
The facial palsy is often unilateral and more frequent 
on the left, being transient and seemingly associated with 
coronary impairment. It resolves spontaneously and com-
pletely, leaving no sequelae. Poon et al.32 published a study 
in 2000 of 28 patients with facial palsy as a KD complica-
tion in patients with 3 to 25 months of age, preferentially 
in females with a 1.4:1 ratio, being transient over a range 
from two days to three months, more frequent on the left; 
54% of the patients also had a coronary aneurism, but only 
one patient had used IV gamma globulin. In the current 
study, the only patient showing a facial palsy was diag-
nosed on the 26th day of disease, experiencing extended fe-
ver, high and long-lasting inflammatory activity. The facial 
palsy had an onset in the subacute phase on the left and 
improved within 30 days with physical therapy and the pa-
tient also had ataxia, hearing loss and a small left coronary 
aneurism. It is important to have a raised suspicion level 
for KD in children with extended fever and facial palsy.
Sensorineural hearing loss, seldom mentioned in lit-
erature, is another serious complication, possibly irrevers-
ible37,42. Sensorineural hearing loss in KD might reflect 
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inner ear abnormalities because of an intense cochlea or 
wall vessel (vasa nervorum and perineural vessels) inflam-
mation, leading to a vasculitis neuropathy43,44.
The number of cases published on sensorineural hear-
ing deficit in KD seems underestimated. Reduced hearing 
acuity may be slight and transient, as the condition is seen 
in small children and it could not be perceived by parents. 
The hearing loss is often detected only by audiometry or, 
in small children in whom tone audiometry is di cult to 
be performed, by brainstem auditory evoked potential as-
sessment (BERA)42. Unlike studies previously conducted, 
our study found a high percentage of patients with senso-
rineural auditory loss both in the first 30 days of disease 
(33%) and in an assessment six months later (11.3%). This 
dierence was likely to occur because prior studies did not 
have BERA performed in all patients and when this oc-
curred, the second assessment was done within a variable 
length of time36,37.
We agree with Knott et al.37 that sensorineural hearing 
loss is a frequent complication in KD, but we disagree with 
these authors that persistent sensorineural hearing loss 
is rare, since we found 11.3% of our patients sustaining a 
hearing loss in an assessment six months later. Similarly, 
we agree with the study by Sundel et al.36 that a high and 
extended inflammatory activity is a risk factor for hearing 
loss in KD, but we observed anemia and thrombocytosis 
are also predisposing factors to a hearing loss in KD42.
Ataxia occurs in the acute and subacute phases and is 
usually transient3. In our study, 30% of patients had ataxia 
in the acute phase and the others, in the subacute phase, 
with its disappearing over convalescence.
CNS lesions may occur and despite their severity, as 
shown in a number of case reports in literature29, they are 
mostly self-limited findings, whose clearing could take 
months, but could also leave sequelae, such as brain atro-
phy, ischemic lesions30, including cognitive and behavioral 
conditions39. Meningoencephalitides, subdural eusions, 
hypoperfused brain, ischemia, cerebral and cerebelar in-
farction are CNS changes also being frequently detected 
from the better KD recognition and from a more extended 
follow-up in these patients26-31. CNS lesions should always 
be considered in KD, mainly in severe cases with high 
and extended inflammatory activity and the presence of a 
coronary impairment with or without neurological mani-
festations31.
Post-mortem histopathological studies in cases of KD 
are scarce. Amano et al.43 found ganglionitis and cranial and 
peripheral nerve neuritis, endoarteritis, periarteritis, cho-
riomeningitis and leptomeningitis, in addition to atrophy, 
degenerative changes with neuron loss, marginal and sub-
ependimal gliosis and glial nodes around degenerated neu-
rons in post-mortem study of 30 children aected by KD.
Ophthalmologic complications, according to case re-
ports found in literature, occur in the acute and subacute 
phases, are usually transient and clear within months of 
the acute phase18. Burns et al.45 assessed 41 patients in KD 
acute phase and observed 27 patients with anterior uve-
itis (25 bilaterally), 5 patients with punctate keratitis and 3 
with keratitis and uveitis. In the current study, 15 patients 
had ophthalmologic complications, such as anterior uve-
itis, papilledema and conjunctival hemorrhage, showing 
transiently in the acute and subacute phases.
Histologically, KD can be a vasculitis in the polyar-
teritis group with a whole-vessel wall involvement and 
as it progresses with vessel fibrinoid necrosis, because of 
the high inflammatory involvement of the vessel, it can 
reach the point of a necrotizing vasculitis up to a periph-
eral gangrene, as seen in case reports in literature22-24. 
The patient having necrotizing vasculitis progressed to 
peripheral gangrene with a tongue tip loss. This patient 
was diagnosed at the subacute phase as KD and showed 
high and extended inflammatory activity associated with 
a major thrombocytosis.
KD is associated with significant behavioral sequelae, 
such as concentration di culty, emotional lability, hyper-
activity, aggressiveness, di culty in social relationship and 
others. These complications should be considered during 
the follow-up of KD patients and they should be referred 
to psychological evaluation. Studies based on Child Be-
havior Check List (CBCL4-18/1991), Strengths and Dif-
ficulties Questionnaire (1997), Parenting Stress Index 
(PSI/1983), such as the study by Conway et al.38 in 2005, 
where anxiety, depression, conditions associated with the 
conduct (aggressiveness, hyperactivity, disobedience and 
argumentative behavior) were found in 40% of patients 
and few social interrelationship or school achievement 
changes were found. King et al.39 2000 study based on the 
same questionnaires, 34% of patients were found with a 
behavior change, such as attention deficit, learning deficit, 
emotional eects (fear of night and night terrors). Inter-
nalization problems predominated (anxious and depres-
sive behavior). In the current study, 20% of patients had 
behavior changes predominating in agreement with Con-
way et al.’s38 findings of conduct changes (aggressiveness, 
hyperactivity, argumentative behavior) and with King 
et al.39 findings, with attention deficit, learning deficit and 
emotional eects (emotional lability) predominating for a 
period of six months after KD acute phase. The most fre-
quent change, occurring usually in the acute phase, is ir-
ritability.
In the current study, the most prevalent KD compli-
cations were sensorineural hearing loss (33%), coronary 
aneurisms (21.7%) and behavior and cognitive disorders 
(20%). As a systemic vasculitis, KD can progress into sev-
eral complications, some of them being transient and oth-
ers possibly leading to permanent sequelae, such as coro-
nary complications, which can lead to death. A number of 
complications can be persistent, as in the case of sequelae 
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caused by brain lesions, sensorineural hearing loss and 
behavior changes, possibly leading to residual disabilities 
with learning and interpersonal relationship damage.
From the data analysis, we can conclude the earlier the 
diagnosis and therapeutic intervention with IVIG are, 
the lower the occurrence of complications will be; the pres-
ence of thrombocytosis, anemia and high and extended 
inflammatory activity are risk factors for complications. In 
addition, maintaining an attentive and periodical patient 
follow-up is important, as many of these complications are 
late in onset and can become permanent.
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